Exagen (XGN) Retained Earnings (2018 - 2025)
Historic Retained Earnings for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to -$309.6 million.
- Exagen's Retained Earnings fell 654.13% to -$309.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$309.6 million, marking a year-over-year decrease of 654.13%. This contributed to the annual value of -$294.3 million for FY2024, which is 541.34% down from last year.
- As of Q3 2025, Exagen's Retained Earnings stood at -$309.6 million, which was down 654.13% from -$302.5 million recorded in Q2 2025.
- Over the past 5 years, Exagen's Retained Earnings peaked at -$187.5 million during Q1 2021, and registered a low of -$309.6 million during Q3 2025.
- In the last 5 years, Exagen's Retained Earnings had a median value of -$268.2 million in 2023 and averaged -$257.2 million.
- As far as peak fluctuations go, Exagen's Retained Earnings crashed by 2276.69% in 2022, and later plummeted by 541.34% in 2024.
- Quarter analysis of 5 years shows Exagen's Retained Earnings stood at -$208.1 million in 2021, then decreased by 22.77% to -$255.5 million in 2022, then fell by 9.27% to -$279.2 million in 2023, then fell by 5.41% to -$294.3 million in 2024, then decreased by 5.19% to -$309.6 million in 2025.
- Its last three reported values are -$309.6 million in Q3 2025, -$302.5 million for Q2 2025, and -$298.1 million during Q1 2025.